Komorbidität rheumatischer und hepatologischer Erkrankungen
Standard
Komorbidität rheumatischer und hepatologischer Erkrankungen. / Mayet, W-J; Lohse, A W.
in: Z RHEUMATOL, Jahrgang 72, Nr. 6, 01.08.2013, S. 547-54.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Komorbidität rheumatischer und hepatologischer Erkrankungen
AU - Mayet, W-J
AU - Lohse, A W
PY - 2013/8/1
Y1 - 2013/8/1
N2 - The correlation between rheumatic diseases and liver diseases is complex and often not given sufficient attention. There are, however, consequences for diagnosis and therapy. Rheumatic diseases can present with hepatic symptoms while liver diseases can exhibit rheumatic symptoms. Examples of liver diseases as a cause of rheumatic symptoms are viral hepatitis B and C, autoimmune hepatitis and hemochromatosis. As a result of rheumatic diseases, such as adult onset Still's disease and systemic lupus erythematosus, liver dysfunction can occur. Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are directly associated with rheumatic diseases and have to be distinguished by way of differential diagnosis. During antirheumatic therapy, serious hepatotoxic side effects have to be expected.
AB - The correlation between rheumatic diseases and liver diseases is complex and often not given sufficient attention. There are, however, consequences for diagnosis and therapy. Rheumatic diseases can present with hepatic symptoms while liver diseases can exhibit rheumatic symptoms. Examples of liver diseases as a cause of rheumatic symptoms are viral hepatitis B and C, autoimmune hepatitis and hemochromatosis. As a result of rheumatic diseases, such as adult onset Still's disease and systemic lupus erythematosus, liver dysfunction can occur. Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are directly associated with rheumatic diseases and have to be distinguished by way of differential diagnosis. During antirheumatic therapy, serious hepatotoxic side effects have to be expected.
KW - Comorbidity
KW - Evidence-Based Medicine
KW - Humans
KW - Liver Diseases
KW - Prevalence
KW - Rheumatic Diseases
KW - Risk Factors
U2 - 10.1007/s00393-012-1116-3
DO - 10.1007/s00393-012-1116-3
M3 - SCORING: Zeitschriftenaufsatz
C2 - 23868731
VL - 72
SP - 547
EP - 554
JO - Z RHEUMATOL
JF - Z RHEUMATOL
SN - 0340-1855
IS - 6
ER -